On February 10, 2016, Mylan (MYL) announced its decision to acquire Meda AB for a consideration of $9.9 billion through a public offer. Unlike the Perrigo (PRGO) deal, this acquisition is expected to ...

SOMERSET, N.J., Sept. 8 Meda Pharmaceuticals Inc. (Meda) today announced the commercial availability of EDLUAR(TM) (zolpidem tartrate sublingual tablets) in the United States. EDLUAR is indicated for ...

Corrections and clarifications: An earlier version of this story misstated Pete Letendre's title. Investors reeled Thursday after pharmaceutical giant Mylan announced a deal to acquire Swedish drug ...

Metropolitan Economic Development Association has hired Emma Kasiga as its new senior loan officer. Kasiga will manage MEDA’s lending activities in alignment with the company’s strategic mission, ...